Canaccord lowered the firm’s price target on Stryker (SYK) to $400 from $435 and keeps a Buy rating on the shares. The firm said they delivered a mixed quarter, with Q1 results coming in below top- and bottom-line expectations due to a cyber incident during the Q that disrupted global operations and delayed shipments and revenue recognition. Importantly, the company emphasized that underlying demand remained healthy across its segments, and it saw the best-ever Q1 for Mako installations both domestically and internationally.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
